Yes — in 2026 researchers reported that plasma p-tau217, a blood marker linked to Alzheimer's-related tau changes, can signal risk up to 10 years before symptoms. For spouses and partners, the result gives early risk information, not a diagnosis. An international team led by Mass General Brigham followed 2,684 cognitively healthy older adults from six cohorts in North America, Japan and Australia, according to the Alzheimer's Association in the AAIC release. A separate long-term study in women extended the window even further.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 studies found
- What do the risk numbers mean for partners?
- Can a healthy partner get tested now?
- How solid is the 10-year estimate?
- What spouses can do next
What the 2026 studies found
The main study measured baseline plasma p-tau217 in people with normal thinking and tracked later mild cognitive impairment or dementia. Adults with very high baseline levels had an estimated 38% risk within 5 years and 78% within 10 years. Even slightly elevated p-tau217 carried about 15% risk at 5 years and 45% at 10 years.
Higher levels also predicted faster decline, strongest in people already amyloid-positive on PET scans. A separate UC San Diego study followed 2,766 women in the Women's Health Initiative Memory Study, according to UC San Diego in the university report. Higher p-tau217 predicted later impairment and dementia up to 25 years before symptoms began.
What do the risk numbers mean for partners?
Absolute risk describes how many people with a given level later developed impairment. Very high means about 38 of 100 within five years and about 78 of 100 within ten years. Slightly above average means lower but real risk, about 15 of 100 at five years and 45 of 100 at ten years.
The gap matters for planning conversations. Think in timelines, not certainties. A high signal supports closer monitoring and earlier planning, while a lower signal does not guarantee protection.
Can a healthy partner get tested now?
FDA-cleared p-tau217 blood tests are cleared only for adults age 55 and older with cognitive symptoms, not routine screening of healthy partners, according to the FDA in the FDA press announcement. That clearance began with Fujirebio Lumipulse on May 16, 2025. The newer Roche Elecsys pTau217 clearance on Aug.
24, 2026 has the same symptomatic-use limit. A spouse without symptoms cannot seek it as a routine check. Ask a clinician about research programs or prevention-trial screening instead of ordering a clinical test alone. Trial settings use strict cutoffs, counseling, and follow-up.
How solid is the 10-year estimate?
The 10-year 78% estimate rests on substantially less follow-up data than the 5-year estimate, according to Neuroscience News reporting the JAMA study in the Neuroscience News report. Most cohorts enrolled from 2004 with last follow-up in 2025. Longer projections therefore have wider uncertainty.
Five-year risk is more firmly supported than ten-year risk. For couples, treat the decade signal as a planning window. It shows direction and rough size, not an exact personal forecast.
What spouses can do next
Researchers describe the decade-ahead signal as prognostic for prevention-trial enrollment and earlier monitoring, not a diagnosis. Use it to organize health, legal, and support steps while thinking is normal.
Bring a dated list of changes to each visit. Small, steady records help clinicians separate normal aging from a meaningful shift.
- Ask the primary-care clinician about memory monitoring and prevention-study referral options
- Track thinking, function, sleep, mood, medications, and vascular risks over time
- Update advance directives, finances, driving plans, and caregiver contacts early
- Build support now through family, community resources, and respite options
You Might Also Like
- Repetitive Heading and Brain Health Findings at AAIC 2026: What Researchers Still Need to Learn for Spouses and Partners
- Dementia With Multiple Etiologies in the 2026 NIA Report: Why the Findings May Not Change Care Yet for Spouses and Partners
- Support for People Without Care Partners in the 2026 NIA Report: What Working Dementia Caregivers Can Check in Their Community





